X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
pharmacology & pharmacy (38) 38
index medicus (35) 35
female (33) 33
microbiology (26) 26
male (24) 24
antimalarials - pharmacokinetics (23) 23
adult (21) 21
pharmacokinetics (17) 17
antimalarials - therapeutic use (15) 15
pharmacology (15) 15
pregnancy (15) 15
population pharmacokinetics (13) 13
malaria (12) 12
antimalarials - administration & dosage (11) 11
chromatography, high pressure liquid (11) 11
dihydroartemisinin-piperaquine (11) 11
malaria, falciparum - drug therapy (11) 11
artemisinins - therapeutic use (10) 10
plasmodium-falciparum malaria (10) 10
animals (9) 9
antimalarials - adverse effects (9) 9
child (9) 9
papua new guinea (9) 9
quinolines - pharmacokinetics (9) 9
artemisinins - pharmacokinetics (8) 8
clinical therapeutics (8) 8
drug therapy, combination (8) 8
malaria - drug therapy (8) 8
milk, human - chemistry (8) 8
piperaquine (8) 8
area under curve (7) 7
artemisinins - administration & dosage (7) 7
child, preschool (7) 7
efficacy (7) 7
infant (7) 7
infant, newborn (7) 7
parasitic diseases (7) 7
vivax malaria (7) 7
analysis (6) 6
children (6) 6
dose-response relationship, drug (6) 6
drug combinations (6) 6
infant dose (6) 6
metabolites (6) 6
middle aged (6) 6
models, biological (6) 6
pyrimethamine - therapeutic use (6) 6
quinolines - therapeutic use (6) 6
sulfadoxine - therapeutic use (6) 6
uncomplicated malaria (6) 6
young adult (6) 6
artemisinins - blood (5) 5
artesunate (5) 5
breast feeding (5) 5
chloroquine (5) 5
chloroquine - pharmacokinetics (5) 5
chloroquine - therapeutic use (5) 5
combination (5) 5
drug administration schedule (5) 5
infectious diseases (5) 5
malaria, vivax - drug therapy (5) 5
mefloquine (5) 5
metabolism (5) 5
mice (5) 5
milk, human - metabolism (5) 5
plasma (5) 5
treatment outcome (5) 5
adolescent (4) 4
analgesics, opioid - pharmacokinetics (4) 4
antimalarial-drug (4) 4
antimalarials - pharmacology (4) 4
azithromycin (4) 4
biological availability (4) 4
chloroquine - administration & dosage (4) 4
dihydroartemisinin (4) 4
disposition (4) 4
health aspects (4) 4
intermittent preventive treatment (4) 4
malaria, falciparum - parasitology (4) 4
new-guinean children (4) 4
plasmodium falciparum - drug effects (4) 4
plasmodium-falciparum (4) 4
reproducibility of results (4) 4
safety (4) 4
serum (4) 4
sulfadoxine-pyrimethamine (4) 4
anabaena-cylindrica (3) 3
antibiotics (3) 3
antimalarials (3) 3
antimalarials - blood (3) 3
artemether-lumefantrine (3) 3
artemisinin (3) 3
azithromycin - administration & dosage (3) 3
azithromycin - adverse effects (3) 3
azithromycin - pharmacokinetics (3) 3
chemistry, analytical (3) 3
chloroquine - analogs & derivatives (3) 3
chromatography, liquid (3) 3
cyanobacterium (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2019, Volume 85, Issue 1, pp. 147 - 159
Aims Infection‐induced inflammation is associated with adverse long‐term outcomes in preterm infants. Pentoxifylline (PTX) is a candidate for adjunct... 
late‐onset sepsis | lisofylline | pentoxifylline | necrotizing enterocolitis | preterm infant | population pharmacokinetics | late-onset sepsis | INFLAMMATION | INJURY | PHARMACOLOGY & PHARMACY | BLOOD
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 24, pp. 2545 - 2557
Journal Article
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2016, Volume 82, Issue 1, pp. 199 - 212
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96810
Background: Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient... 
COUNTERFEIT | SOUTHEAST-ASIA | PHARMACOKINETICS | PYRIMETHAMINE | MALARIA CASE-MANAGEMENT | MULTIDISCIPLINARY SCIENCES | HPLC METHOD | MEDICINES | PRIMAQUINE | SUBSTANDARD | ANTI-MALARIALS | Papua New Guinea | Humans | Amodiaquine - analysis | Artemisinins - standards | Antimalarials - standards | Antimalarials - analysis | Quinine - therapeutic use | Primaquine - analysis | Chloroquine - standards | Amodiaquine - therapeutic use | Drug Resistance | Quality Control | Malaria, Falciparum - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Biosimilar Pharmaceuticals - standards | Quinine - analysis | Amoxicillin - standards | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - analysis | Quinine - standards | Artemisinins - analysis | Artemisinins - therapeutic use | Health Facilities | Malaria, Vivax - drug therapy | Primaquine - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - analysis | Amodiaquine - standards | Biosimilar Pharmaceuticals - analysis | Primaquine - standards | Surveys | Plasmodium falciparum | Health facilities | Antibiotics | Malaria | Primaquine | Amoxicillin | Liquid chromatography | Drug resistance | Health aspects | Logistics | Drugs | Laboratories | Supply chains | Artemisinin | Licenses | Quality | Drug dosages | Public health | Vector-borne diseases | Procurement | Medical research | Health risks | Pyrimethamine | Health centres | Pharmacology | High-performance liquid chromatography | Quinine | Counterfeiting | Hospital facilities | Storage conditions | Pharmacy | Quality control | Regulatory mechanisms (biology) | Amodiaquine | Artemether | Warehouses | Drug stores | High performance liquid chromatography | Pharmaceuticals
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2472 - 2484
Journal Article